Innoviva
INVA
#5382
Rank
HK$12.48 B
Marketcap
HK$169.19
Share price
1.41%
Change (1 day)
10.53%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): HK$4.68 Billion

According to Innoviva's latest financial reports the company's current earnings are HK$0.42 Billion. In 2025 the company made an earning of HK$2.56 Billion, an increase over its 2024 earnings that were of HK$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$4.68 B82.91%
2025 HK$2.56 B774.24%
2024 HK$0.29 B-80.74%
2023 HK$1.52 B-32.36%
2022 HK$2.24 B-35.56%
2021 HK$3.49 B25.7%
2020 HK$2.77 B52.11%
2019 HK$1.82 B10.77%
2018 HK$1.64 B56.59%
2017 HK$1.05 B125.53%
2016 HK$0.46 B-417.36%
2015 -HK$0.15 Billion-74.49%
2014 -HK$0.58 Billion-25.19%
2013 -HK$0.78 Billion430.06%
2012 -HK$0.15 Billion-83.92%
2011 -HK$0.91 Billion39.82%
2010 -HK$0.65 Billion2.84%
2009 -HK$0.63 Billion-8.62%
2008 -HK$0.69 Billion-47.92%
2007 -HK$1.33 Billion-5.92%
2006 -HK$1.41 Billion19.8%
2005 -HK$1.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$1.8 Billion-138.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion-103.03%๐Ÿ‡บ๐Ÿ‡ธ USA